These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26950554)

  • 1. Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa.
    van der Walt M; Lancaster J; Shean K
    PLoS One; 2016; 11(3):e0144249. PubMed ID: 26950554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
    BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
    PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
    Chem ED; Van Hout MC; Hope V
    BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa.
    Mokhele I; Jinga N; Berhanu R; Dlamini T; Long L; Evans D
    BMC Pregnancy Childbirth; 2021 Jun; 21(1):453. PubMed ID: 34182944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
    Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.
    Farley JE; Ram M; Pan W; Waldman S; Cassell GH; Chaisson RE; Weyer K; Lancaster J; Van der Walt M
    PLoS One; 2011; 6(7):e20436. PubMed ID: 21799728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.
    Brust JC; Lygizos M; Chaiyachati K; Scott M; van der Merwe TL; Moll AP; Li X; Loveday M; Bamber SA; Lalloo UG; Friedland GH; Shah NS; Gandhi NR
    PLoS One; 2011 Jan; 6(1):e15841. PubMed ID: 21253585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.
    Hicks RM; Padayatchi N; Shah NS; Wolf A; Werner L; Sunkari VB; O'Donnell MR
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1074-83. PubMed ID: 25189555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.
    Daniels JF; Khogali M; Mohr E; Cox V; Moyo S; Edginton M; Hinderaker SG; Meintjes G; Hughes J; De Azevedo V; van Cutsem G; Cox HS
    PLoS One; 2015; 10(11):e0142873. PubMed ID: 26555134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
    Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
    PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Treatment Success Rates Among HIV-Infected Multidrug-Resistant Tuberculosis Patients After Expansion of Antiretroviral Therapy in Botswana, 2006-2013.
    Shin SS; Modongo C; Boyd R; Caiphus C; Kuate L; Kgwaadira B; Zetola NM
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):65-71. PubMed ID: 27552155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.
    Satti H; McLaughlin MM; Hedt-Gauthier B; Atwood SS; Omotayo DB; Ntlamelle L; Seung KJ
    PLoS One; 2012; 7(10):e46943. PubMed ID: 23115633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
    PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa.
    Mohr E; Cox V; Wilkinson L; Moyo S; Hughes J; Daniels J; Muller O; Cox H
    Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):425-32. PubMed ID: 25979526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality and treatment success of multi-drug resistant and Rifampicin resistant tuberculosis in Zimbabwe: a retrospective cohort analysis of patients initiated on treatment during 2010 to 2015.
    Matambo R; Nyandoro G; Sandy C; Nkomo T; Mutero-Munyati S; Mharakurwa S; Chikaka E; Ngwenya M; Ndongwe G; Pepukai VM
    Pan Afr Med J; 2021; 39():128. PubMed ID: 34527144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.